Lymphodepletion, tumor-infiltrating lymphocytes, and high versus low dose IL-2 followed by pembrolizumab in patients with metastatic melanoma by Merve Hasanov, Simin Kiany, Marie-Andrée Forget, Roland Bassett, Michael A. Davies, Adi Diab, Jeffrey E. Gershenwald, Isabella C. Glitza, Jeffrey E. Lee, Anthony Lucci, Jennifer L. McQuade, Sapna P. Patel, Merrick I. Ross, Hussein A. Tawbi, Jennifer A. Wargo, Michael K. Wong, Chantale Bernatchez, Patrick Hwu, Cara Haymaker, Rodabe N. Amaria

Get full text

FDG-PET associations with pathological response and survival with neoadjuvant immunotherapy for melanoma by Sydney Ch’ng, María González, Ines Pires da Silva, Rodabe N Amaria, Li Zhou, Shahneen Sandhu, Georgina V Long, Zeynep Eroglu, David E Gyorki, Richard A Scolyer, Andrew J Spillane, George Au-Yeung, Elizabeth M Burton, Christian U Blank, Hussein A Tawbi, Robert V Rawson, Alexander M Menzies, Matteo S Carlino, Igor Samoylenko, Serigne N Lo, Robyn P M Saw, Kerwin F Shannon, Alexander C J van Akkooi, Milton Jose Barros e Silva, Edward Hsiao, Thomas E Pennington, Rony Kapoor, João Pedreira Duprat, Rafaela Brito de Paula

Get full text